Skip to content

The effect of prebiotics on premature infants

Neutral oligosaccharides effectiveness on incidence of Suspected NEC in VLBW infants in Al-Zahra and Shahid beheshti hospitals in Isfahan

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013090710026N2
Enrollment
60
Registered
2013-09-22
Start date
2013-07-02
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suspected NEC. Necrotizing enterocolitis of fetus and newborn

Interventions

Intervention 1: In the prebiotc given group(pb) after consideration the inclusion and exclusion criteria for premature infants<1500gr that their milk volume is reached to 30cc/kg/day, 0.5 gr/kg/day mi
Treatment - Other
Placebo
In the prebiotc given group(pb) after consideration the inclusion and exclusion criteria for premature infants<1500gr that their milk volume is reached to 30cc/kg/day, 0.5 gr/kg/day mixture of scGOS +
In placebo groups(p) after consideration the inclusion and exclusion criteria, for premature infants<1500gr that their volume of milk reaches to 30cc/kg/day, prebiotic mixture will not be added to t

Sponsors

Isfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 30 Years

Inclusion criteria

Inclusion criteria: Inclusion critreria: prematurity-birth weight equal and lower than 1500gr and milk volume reached to 30cc/kg/day. Exclusion criteria: major congenital anomalies; asphyxia; GI anomalies; congenital cyanotic heart disease.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Suspected NEC. Timepoint: 30. Method of measurement: Patient examination and observation.;GI microbial changes. Timepoint: 30 days. Method of measurement: Stool exam.

Secondary

MeasureTime frame
Time of becoming full volume milk. Timepoint: 30 days. Method of measurement: Daily recorded sheets.;Milk intolerance. Timepoint: 30 days. Method of measurement: Daily recorded sheets.;Hospital stay. Timepoint: 30 days. Method of measurement: Daily recorded sheets.;NPO duration. Timepoint: 30 days. Method of measurement: Daily recorded sheets.;Death. Timepoint: During hospital stay. Method of measurement: Daily recorded sheets.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Maryam Hosseinzadeh

Isfahan University of Medical Sciences

dr_mhosseinzadeh@yahoo.com+98 31 1459 4676

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026